Assessment of Volumetric Hemodynamic Parameters and Nutritional Status in Stable Renal Transplant Recipients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-07-31

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Changes in volumetric hemodynamic parameters and fluid overload (Cardiac Index,Stroke Volume, Thoracic Fluid Content, Systemic Vascular Resistance) were measured using a impedance cardiography (ICG) (CardioScreen 1000 - Haemodynamic Measurement System, Medis. Ilmenau) in stable renal transplant recipients Nutritional status was measured by Tanita 418 Monitor.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients

NCT02908139

Arterial Calcification Aortic Stiffness High Blood Pressure +1 more

UNKNOWN

Short and Long-term Results of Arterial Stiffness and Central Aortic Pressure After Kidney Transplantation

NCT02443454

Arterial Calcification Aortic Stiffness High Blood Pressure (& [Essential Hypertension])

COMPLETED

Prospective Single-center Study Evaluating the Central Blood Pressure in Renal Transplantation

NCT02528591

Kidney Transplant

COMPLETED NA

A Study of Novel Biomarkers of Kidney Dysfunction at Liver Transplant

NCT03376009

Liver Transplantation Liver Transplant; Complications Kidney Dysfunction

COMPLETED

Clinical Impact of Hypothermic Machine Perfusion in Renal Transplant Recipients

NCT02621281

Delayed Function of Renal Transplant

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Output, Low High Blood Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients after kidney transplantation

The study included who had been admitted to a nephrology-transplantation outpatient clinic 0.5 to 30 years after kidney transplantation.

CardioScreen 1000

Intervention Type DEVICE

Haemodynamic Measurement System, Medis Impedance cardiography (ICG)

Tanita 418- Bioelectrical impedance analysis

Intervention Type DEVICE

The device measured the size of total body water (TBW), fat mass (FM%), visceral fat%, fat free mass (FFM), and basal metabolic rate (BMR) (kcal).

Healthy subjects

Medical staff: medical doctors, nurses

CardioScreen 1000

Intervention Type DEVICE

Haemodynamic Measurement System, Medis Impedance cardiography (ICG)

Tanita 418- Bioelectrical impedance analysis

Intervention Type DEVICE

The device measured the size of total body water (TBW), fat mass (FM%), visceral fat%, fat free mass (FFM), and basal metabolic rate (BMR) (kcal).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CardioScreen 1000

Haemodynamic Measurement System, Medis Impedance cardiography (ICG)

Intervention Type DEVICE

Tanita 418- Bioelectrical impedance analysis

The device measured the size of total body water (TBW), fat mass (FM%), visceral fat%, fat free mass (FFM), and basal metabolic rate (BMR) (kcal).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* give voluntary consent to participate in the study
* functioning graft longer than 3 months to 10 years
* no clinical cardiovascular disease during the 6 months preceding entry
* stable graft function- glomerular filtration rate \> 30 ml/min/1.73 m2, creatinine concentration \<2.5 mg/dl
* medical staff (medical doctors, nurses)